Amgen Inc. (AMGN) News Headlines

▮ More

Date

Headline

9/13/2022 8:12:59 AM Amgen To Present At Morgan Stanley's 2022 Global Healthcare Conference; Webcast At 9:10 AM ET

9/12/2022 5:28:03 AM Amgen Announces Positive Result For Phase 1b Study Of Combination Of Vectibix, Lumakras

9/12/2022 4:43:49 AM Amgen Announces Updated Data From Phase 1b CodeBreaK 101 Study

9/8/2022 9:06:20 AM Amgen: Phase 3 Studies Of Oral Otezla Shows Efficacy In Moderate To Severe Psoriasis

9/8/2022 8:48:27 AM Amgen : SPROUT Data Show Otezla Resulted In Improvements In Measures Of Moderate To Severe Plaque Psoriasis

9/8/2022 8:45:08 AM Amgen To Present At Wells Fargo's 2022 Global Healthcare Conference; Webcast At 9:45 AM ET

9/7/2022 7:52:42 AM Amgen To Present At Citi's 2022 Global Healthcare Conference; Webcast At 8:50 AM ET

8/29/2022 3:26:46 AM Amgen Presents New Compelling Data From The Phase 3 FOURIER OLE Studies Of Repatha At ESC

8/23/2022 9:31:03 AM Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

8/23/2022 9:06:07 AM Amgen Announces Positive Results From Phase 3 Study Of ABP 959 In Paroxysmal Nocturnal Hemoglobinuria

8/4/2022 4:05:37 PM Amgen Inc. Announces Increase In Q2 Profit

8/4/2022 4:03:30 PM Amgen Q2 EPS $2.45 Vs. $0.81 Year Ago

8/4/2022 8:47:58 AM Amgen To Buy TAVNEOS Developer ChemoCentryx In $3.7 Bln Cash Deal

8/4/2022 8:02:15 AM Amgen To Buy ChemoCentryx For $52/Shr Cash, Representing An Enterprise Value Of About $3.7 Bln

8/4/2022 6:00:15 AM Amgen Q2 22 Earnings Conference Call At 5:00 PM ET

8/3/2022 4:13:10 PM Amgen Appoints Michael Drake To Its Board Of Directors

8/3/2022 4:02:19 PM Amgen Declares Q3 Dividend Of $1.94/share, Payable Sept. 8/ Record Aug. 18

8/3/2022 4:01:42 PM Amgen Inc. (AMGN) Declares $ 1.94 Dividend for Q3 22, Record Date 8/18/2022

7/25/2022 2:59:36 AM AstraZeneca: CHMP Recommends Tezspire For Severe Asthma In EU

6/15/2022 12:40:06 PM Amgen To Present At Goldman Sachs Healthcare Conference; Webcast At 1:40 PM ET